Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Cardiovascular Regenerative Medicine, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, New York, NY, USA.
Curr Cardiol Rep. 2023 Jul;25(7):615-620. doi: 10.1007/s11886-023-01886-7. Epub 2023 Jun 2.
This review explores efforts made over the previous three decades to determine mechanisms of cardiomyocyte cell division. Many investigators have explored cell therapy strategies in animal models and clinical trials over the past 2 decades with marginal results thus far in clinical testing. Hence, there is a greater focus now on strategies to induce cardiomyocyte proliferation.
Reports to induce reactivation of the cardiomyocyte cell cycle predated the focus on cell therapy, and we summarize the literature on this topic, which began with the very first transgenic mouse studies in cardiovascular science. These earlier studies form the foundation for the use of cell cycle manipulation in cardiac repair and should inform current and future investigations with respect to rigor of assessment in the degree of cardiomyocyte cell division and gold standard measures of cardiac functional improvement.
本综述探讨了过去三十年确定心肌细胞分裂机制的努力。许多研究人员在过去 20 年中在动物模型和临床试验中探索了细胞治疗策略,但迄今为止临床测试的结果微乎其微。因此,现在更多地关注诱导心肌细胞增殖的策略。
诱导心肌细胞周期再激活的报告早于细胞治疗的重点,我们总结了这方面的文献,该文献始于心血管科学中第一个转基因小鼠研究。这些早期研究为心脏修复中细胞周期操作的使用奠定了基础,并应告知当前和未来的研究在评估心肌细胞分裂程度和心脏功能改善的黄金标准措施方面的严谨性。